Jefferson Capital Upsizes Notes, Interrupting a Deleveraging Streak
Jefferson Capital priced a $100 million add-on to its 2030 notes, pushing the tranche to $600 million just as three straight quarters of falling leverage were set to continue.
Jefferson Capital, Inc. (JCAP), the debt-purchasing and recovery company, priced a $100 million add-on to its 8.250% senior notes due 2030, upsizing the tranche issued under its May 2, 2025 indenture to $600 million. The offering is expected to close August 20, 2026, with proceeds earmarked to repay revolver borrowings and for general corporate purposes. The notes are guaranteed by certain wholly owned domestic restricted subsidiaries, the first incremental note issuance disclosed since the original $500 million tranche.
The timing sits against a run of deleveraging. Jefferson Capital's leverage ratio fell for three consecutive reported quarters, from 2.72x on a year-ago comparison basis to 1.82x in the fourth quarter of 2025, then to 1.79x in the first quarter of 2026 and 1.71x in the second. The new $100 million add-on does not by itself reverse that arithmetic, since the proceeds are directed at repaying revolver debt rather than adding net leverage, but it does mark a shift from a company that had spent a year paying down borrowings to one raising fresh long-term debt in the public markets.
The add-on arrived five days after Jefferson Capital's second-quarter earnings release, filed August 13, 2026, which carried none of the incremental-debt language and instead led with operating results. Collections grew 18% year over year to $300.9 million, deployments grew 21% to $152.2 million, and estimated remaining collections rose 18% to $3.4 billion. Revenue climbed 16% to $177.5 million, with pretax income of $53.3 million and net income of $41.3 million, or $0.67 a share; adjusted earnings came to $0.77 a share.
The deployment figure marks a reversal. In the first quarter, deployments had fallen 14.6% year over year to $149.7 million even as collections hit a record $309.9 million, up 19%. By the second quarter, deployments swung back to growth while collections growth eased slightly to 18% and the dollar total slipped to $300.9 million from the prior quarter's $309.9 million. The pattern points to a company that pulled back on buying receivables early in the year and then reaccelerated capital deployment even as the pace of cash collected off its existing portfolio cooled.
Revenue growth has settled into a narrower band than it once occupied. Second-quarter revenue rose 16% and first-quarter revenue rose roughly 14%, both a step down from the 30% year-over-year growth Jefferson Capital reported for the fourth quarter of 2025. The deceleration has not shown up in per-share results: adjusted earnings per share rose each of the last three reported quarters, from $0.69 in the fourth quarter of 2025 to $0.73 in the first quarter of 2026 and $0.77 in the second. The company's cash efficiency ratio, a measure of collections converted to cash after costs, has held in a narrow low-to-mid-70s range over the same span — 71.0%, 73.0% and 72.2% — without a clear directional trend.
With the add-on set to close August 20, Jefferson Capital will carry $600 million outstanding on the 2030 tranche into a period where deployments are accelerating again and collections growth, while still in the high teens, has begun to soften from its first-quarter pace. Whether the deleveraging trend that ran through the first half of 2026 resumes will depend on how quickly the new notes' proceeds work through the revolver paydown the company has outlined.